yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q38989374-CBF990EA-B248-43B6-9354-453F5D038668
Q38989374-CBF990EA-B248-43B6-9354-453F5D038668
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38989374-CBF990EA-B248-43B6-9354-453F5D038668
Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview.
P2860
Q38989374-CBF990EA-B248-43B6-9354-453F5D038668
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38989374-CBF990EA-B248-43B6-9354-453F5D038668
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
813ee6c28ab32b9f6c9aab23bd71bd93266a951c
P2860
LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models